Pain

Novick D, Montgomery W, Aguado J, Kadziola Z, Peng X, Brugnoli R. Course of pain and outcomes of depression. Results from a three - month, prospective, observational study from Asia. Poster presented at the Eleventh Workshop on Costs and Assessment in Psychiatry; March 2013. Venice, Italy. [abstract] J Ment Health Policy Econ. 2013 Mar; 16(Suppl 1):S27-8.


Abstract not available at this time.

Rothman KJ, Monson RR. The epidemiology of trigeminal neuralgia. J Chronic Dis. 1973 Jan;26(1):3-12.


Hong J, Novick D, Montgomery W, Aguado J, Dueñas H, Peng X, Haro JM. Should unexplained painful physical symptoms be considered within the spectrum of depressive symptoms? Clin Pract Epidemiol Ment Health. 2015 Mar 31;11:130-9. doi: 10.2174/1745017901511010130


OBJECTIVE: To examine whether painful physical symptoms (PPS) can be considered within the spectrum of depressive symptoms.

Stürmer T, Schneeweiss S, Brookhart MA, Rothman KJ, Avorn J, Glynn RJ. Analytic strategies to adjust confounding using exposure propensity scores and disease risk scores: nonsteroidal antiinflammatory drugs and short-term mortality in the elderly. Am J Epidemiol. 2005 May 1;161(9):891-8.


Solidaki E, Chatzi L, Bitsios P, Markatzi I, Plana E, Castro F. Work-related and psychological determinants of multisite musculoskeletal pain. Scand J Work Environ Health. 2010 Jan;36(1):54-61.


OBJECTIVE: Musculoskeletal pain is associated with occupational physical activities and psychosocial risk factors. We evaluated the relative importance of work-related and psychological determinants of the number of anatomical sites affected by musculoskeletal pain in a cross-sectional survey.

Mladsi DM, Goyal RK, Cryer B, Hopkins WE, Brater CD, Korsnes JS, Candrilli SD, Castellsague J, Varas-Lorenzo C. Risk of cardiovascular, gastrointestinal, and renal adverse events associated with diclofenac immediate and extended release drug products: an observational study using US claims data. Poster presented at the 2015 ISPOR 20th Annual International Meeting; May 2015. Philadelphia, PA. [abstract] Value Health. 2015 May; 18(3):A292.


OBJECTIVES: Safety studies have shown that risks associated with use of non-steroidal anti-inflammatory drugs (NSAIDs) are related to dose and release form; however, there is little US evidence. This study assessed the relationships between diclofenac dose and release form on gastrointestinal (GI), cardiovascular (CV), and renal events using US health care claims.

Neighbors DM, Bell T, Wilson TJ, Dodd SL. A three-phased decision analytic model for the economic evaluation of opioid therapy for chronic pain. Poster presented at the 1999 ISPOR 4th Annual International Meeting; May 1999. Arlington, VA.

Abstract not available at this time.

Neighbors DM, Lopez R, Ingham M, Bell TJ. A Canadian adaptation of a decision analytic model for the economic evaluation of opioids for chronic pain. Poster presented at the 2000 ISPOR 3rd Annual European Congress; November 2000. Antwerp, Belgium.


Abstract not available at this time.

Sánchez Matienzo D, Gimeno V, Castellsague J, Arana A. Safety profile of smell and taste disorders in patients treated with cox-2 specific inhibitors and other selected drugs. Presented at the 19th International Conference on Pharmacoepidemiology; 2003.

Abstract not available at this time

Williams VS, Smith MY, Fehnel SE. Use of bpi interference measures for assessing change in impact of pain. Poster presented at the 23rd Annual Scientific Meeting of the American Pain Society; May 2004.

Abstract not available at this time

Subscribe to Pain

How Can We Help You?